BridgeBio to Participate in the Bank of America Merrill Lynch Global Healthcare Conference 2025

Rhea-AI Summary

BridgeBio Pharma (NASDAQ: BBIO), a biopharmaceutical company specializing in genetic diseases, has announced its participation in the upcoming Bank of America Merrill Lynch Global Healthcare Conference 2025. The company's management team will engage in a fireside chat on Wednesday, May 14 at 2:20 PM PT in Las Vegas, NV.

Investors and interested parties can access the live webcast through BridgeBio's investor relations website. A replay will remain available for 30 days following the presentation.

News Market Reaction – BBIO

-3.03%

-3.03% Session move

In the trading session that priced this news, BBIO declined 3.03%, reflecting a moderate negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

PALO ALTO, Calif., May 07, 2025 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a new type of biopharmaceutical company focused on genetic diseases, today announced that members of its management team will participate in a fireside chat at the Bank of America Merrill Lynch Global Healthcare Conference 2025 in Las Vegas, NV on Wednesday, May 14 at 2:20 pm PT.

To access the live webcast of BridgeBio’s presentation, please visit the “Events” page within the Investors section of the BridgeBio website at http://investor.bridgebio.com. A replay of the webcast will be available on the BridgeBio website for 30 days following the event.

About BridgeBio Pharma, Inc.
BridgeBio Pharma, Inc. (BridgeBio) is a new type of biopharmaceutical company founded to discover, create, test, and deliver transformative medicines to treat patients who suffer from genetic diseases. BridgeBio’s pipeline of development programs ranges from early science to advanced clinical trials. BridgeBio was founded in 2015 and its team of experienced drug discoverers, developers and innovators are committed to applying advances in genetic medicine to help patients as quickly as possible. For more information visit bridgebio.com and follow us on LinkedIn, Twitter, Facebook, and YouTube.

BridgeBio Media Contact:
Bubba Murarka, Executive Vice President
contact@bridgebio.com  
(650)-789-8220

BridgeBio Investor Contact:
Chinmay Shukla, VP Strategic Finance
ir@bridgebio.com

FAQ

When is BridgeBio (BBIO) presenting at the Bank of America Healthcare Conference 2025?

BridgeBio will present at the conference on Wednesday, May 14, 2025, at 2:20 PM PT in Las Vegas, NV.

How can I watch BridgeBio's (BBIO) presentation at the Bank of America Healthcare Conference?

The presentation can be accessed through the live webcast on BridgeBio's investor relations website at http://investor.bridgebio.com under the 'Events' page.

How long will BridgeBio's (BBIO) conference presentation replay be available?

The webcast replay will be available on BridgeBio's website for 30 days following the event.

What type of presentation will BridgeBio (BBIO) give at the Bank of America Healthcare Conference?

BridgeBio's management team will participate in a fireside chat format presentation at the conference.